Managing Atopic Diseases across Age Group Dr. Kamal Kant Kohli27 Feb 2023 6:00 AM GMTAtopy is a genetic tendency to produce high IgE antibodies in response to common allergens, which increases the risk of developing atopic illnesses...
United Airway Disease and Clinical Applicability of Montelukast Fexofenadine Combination: Review Dr. Kamal Kant Kohli20 Oct 2022 7:00 AM GMTRecent epidemiological, pathophysiological, and clinical scientific evidence has identified a relationship between upper and lower respiratory...
Respiratory Allergies in India and Clinical Review of Montelukast Fexofenadine Combination in its Management Dr. Kamal Kant Kohli24 Sep 2022 6:27 AM GMTAllergic respiratory diseases (ARDs) are caused by the production of IgE antibodies to airborne allergens, causing various clinical manifestations in...
Allergic Rhinitis in Children: Practitioners Update and Consideration for Use of Intranasal Fluticasone Based Therapies Dr. Kamal Kant Kohli23 Aug 2022 7:15 AM GMTAllergic rhinitis (AR), an inflammatory disease caused by an IgE-mediated immune response to inhaled allergens, is a frequently occurring childhood...
